Efficient Modification of the CCR5 Locus in Primary Human T Cells With megaTAL Nuclease Establishes HIV-1 Resistance. - Wikidata - wikimedia - TriplyDB

Efficient Modification of the CCR5 Locus in Primary Human T Cells With megaTAL Nuclease Establishes HIV-1 Resistance.

Efficient Modification of the CCR5 Locus in Primary Human T Cells With megaTAL Nuclease Establishes HIV-1 Resistance.

http://www.wikidata.org/entity/Q37256197

about

HIV Receives a "One Two Knockout Punch".Tuning DNA binding affinity and cleavage specificity of an engineered gene-targeting nuclease via surface display, flow cytometry and cellular analyses.Engineering HIV-Resistant, Anti-HIV Chimeric Antigen Receptor T Cells.Crystallographic analyses illustrate significant plasticity and efficient recoding of meganuclease target specificity.The Role of Natural Antibodies to CC Chemokine Receptor 5 in HIV Infection.Alterations of expression of inflammation/immune-related genes in the dorsal and ventral striatum of adult C57BL/6J mice following chronic oxycodone self-administration: a RNA sequencing study.Three new active members of the I-OnuI family of homing endonucleases.

P2860

Q38957108-069BE799-B4C4-4422-928B-7318874F522A Q40057209-58E0DFB4-957F-4294-B249-7C6E720D6E69 Q40351372-073AD6AC-0B80-4173-9A00-DF4C568C9C4E Q44166529-6E366036-B153-4D74-8D37-3890A688EA94 Q47107303-A47713A6-6CC8-4B83-A854-C65EA66D8D2D Q48222965-4A418BC7-1464-48DF-B2BC-81E8843864EC Q51054238-DB689770-716E-402B-80F5-DE4DF81EB6ED

P2860

Efficient Modification of the CCR5 Locus in Primary Human T Cells With megaTAL Nuclease Establishes HIV-1 Resistance.

http://www.wikidata.org/entity/Q37256197

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 23 August 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Efficient Modification of the ...... Establishes HIV-1 Resistance.

@en

Efficient Modification of the ...... Establishes HIV-1 Resistance.

@nl

type

label

Efficient Modification of the ...... Establishes HIV-1 Resistance.

@en

Efficient Modification of the ...... Establishes HIV-1 Resistance.

@nl

prefLabel

Efficient Modification of the ...... Establishes HIV-1 Resistance.

@en

Efficient Modification of the ...... Establishes HIV-1 Resistance.

@nl

P1433

Q37256197-E9CDE430-0DE6-4707-A385-7B6AD38E2C32

P1476

Q37256197-96B2608D-B59B-4305-8D78-5D939308CE4C

P2093

Q37256197-19B5280F-0D0A-412F-9F15-139FEADF0ADA

Q37256197-20B8064E-4357-4971-BCF5-4B3FDF18FF28

Q37256197-32764194-2DEC-4FD5-AA65-7B66FABDFD78

Q37256197-4F1311F4-623E-4400-96F9-0C39D2E53B72

Q37256197-5DB3D452-B1C7-417D-9926-61FFE9778AA9

Q37256197-66C7DAA3-55B0-4541-AC18-45BEB228FDBD

Q37256197-67B92D1D-4B5B-4A15-AAFE-14862D232203

Q37256197-6FE6F112-B448-427B-A146-65659FFBC611

Q37256197-7352178A-F146-46A2-9DFF-344D90393454

Q37256197-7C0C215B-7863-4C55-A771-B6D955786F07

P2860

Q37256197-067835E5-0AFD-48E3-B041-1F67CDB16B48

Q37256197-0E332302-4300-4881-BDCF-0BEC33CA7E04

Q37256197-0E8A809A-4431-486E-8EC6-5202DF305FF7

Q37256197-10813B81-8E66-4531-B704-DB0CE7E6E74A

Q37256197-1EA2659E-121E-4B5B-A526-11FB3A482856

Q37256197-24665DD9-3246-4DCE-BF05-98BD5C45ACA9

Q37256197-2D7E4810-CBD6-4F2B-BDE4-48B927D6E63A

Q37256197-2E3862A3-3237-4312-B8A5-75EC3559458D

Q37256197-2FE41118-E61B-4BED-AE33-DD7E5ADF3D74

Q37256197-35E8B935-8E78-46E5-A547-A0E0F0F87B61

P304

Q37256197-B7AC99E1-024C-4BB4-8EE6-7496EB0E1A50

P31

Q37256197-07131E70-C3D9-4912-9FED-EE30686AEB48

P356

Q37256197-CB7249DF-09FB-4AF1-8EFF-983207ACF9F5

P433

Q37256197-7D654D9B-4741-4D62-98E4-445819DE8872

P478

Q37256197-F921B7E4-0366-4DDA-B3D3-2CDAE58E4E9C

P577

Q37256197-9CC5BF01-2C9C-4091-B119-5E1D9BA532C3

P698

Q37256197-0348BA74-0EEA-4A6B-990C-CB93CCAD9130

P932

Q37256197-D23FAB61-9E04-43E4-904D-494BC145D3FF

P356

P1433

Molecular therapy. Nucleic acids

P1476

Efficient Modification of the ...... Establishes HIV-1 Resistance.

@en

P2093

Alexander Astrakhan

http://www.w3.org/2001/XMLSchema#string

Barry Stoddard

http://www.w3.org/2001/XMLSchema#string

Biswajit Paul

http://www.w3.org/2001/XMLSchema#string

Blythe D Sather

http://www.w3.org/2001/XMLSchema#string

David J Rawlings

http://www.w3.org/2001/XMLSchema#string

Guillermo S Romano Ibarra

http://www.w3.org/2001/XMLSchema#string

Hans-Peter Kiem

http://www.w3.org/2001/XMLSchema#string

John P Kowalski

http://www.w3.org/2001/XMLSchema#string

Jordan Jarjour

http://www.w3.org/2001/XMLSchema#string

Karen Sommer

http://www.w3.org/2001/XMLSchema#string

P2860

CCR5 deficiency increases risk of symptomatic West Nile virus infection

Hematopoietic-stem-cell-based gene therapy for HIV disease

Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV

Highly efficient endogenous human gene correction using designed zinc-finger nucleases

Gutless adenovirus: last-generation adenovirus for gene therapy

Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation

Membrane-anchored peptide inhibits human immunodeficiency virus entry.

Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection

Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation

Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases

P304

e352

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MTNA.2016.56

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2016-08-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27741222

http://www.w3.org/2001/XMLSchema#string

P932

5023401

http://www.w3.org/2001/XMLSchema#string